OVERVIEW
The global market for hemodynamic monitoring systems is expected to reach USD 1.214 million by 2024, growing over the forecast period at a CAGR of 5.93%. The key factors driving the growth of the market include increased research into hemodynamic monitoring systems, influx of VC capital, increased prevalence of cardiovascular diseases & diabetes, industry players ‘ awareness initiatives, and government emphasis on critical care infrastructure & services
TABLE OF CONTENT
1 Global Hemodynamic Monitoring Systems Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Hemodynamic Monitoring Systems Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Hemodynamic Monitoring Systems Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Hemodynamic Monitoring Systems Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Hemodynamic Monitoring Systems Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Hemodynamic Monitoring Systems Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Hemodynamic Monitoring Systems Market – By Product (Market Size – &
million/billion)
8.1 Monitors
8.2 Disposables
9 Global Hemodynamic Monitoring Systems Market – By Type
9.1 Invasive
9.2 Minimally invasive
9.3 Noninvasive
10 Global Hemodynamic Monitoring Systems Market – By End-User
10.1 Hospitals
10.2 Clinics and ambulatory care centers
10.3 Home care settings
11 Global Hemodynamic Monitoring Systems Market – By Geography (Market Size – &
million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa
12 Global Hemodynamic Monitoring Systems Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships
13 Global Hemodynamic Monitoring Systems Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Edwards Lifesciences Corporation
13.3 Pulsion Medical Systems Se (Part of the Maquet Getinge Group)
13.4 Lidco Group
13.5 Cnsystems Medizintechnik GmbH
13.6 Deltex Medical Group PLC
13.7 Cheetah Medical
13.8 NI Medical
13.9 ICU Medical
13.10 Caretaker Medical
13.11 Osypka Medical GmbH
13.12 Company 11 & more
14 Global Hemodynamic Monitoring Systems Market – Appendix
14.1 Sources
14.2 Abbreviations